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Prior studies on the function ofdendritic cells have emphasized their ability to
stimulate resting T lymphocytes in such systems as the MLR and polyclonal re-
sponses to mitogens like sodium periodate (1-6). However, dendritic cells isolated
from the epidermis (Langerhans cells [LC])' a nonlymphoid tissue, are weak ac-
cessory cells (7, 8). These LC must be cultured for 1-3 d with the cytokine granulo-
cyte/macrophage CSF (GM-CSF) to become active stimulators ofthe MLR and
polyclonal T cell mitogenesis (9, 10).
Here we have studied the efficacy of different types of dendritic cells to present
a protein, myoglobin, to T cell clones for which immunogenic peptide fragments
have been defined (11). We will show that the capacity of the dendritic cell popula-
tionto present protein varies inversely with stimulating activity in the MLR. Freshly
isolated epidermal LC actively present intact myoglobin, while cultured LC and
spleen dendritic cells do not. These findings suggest that dendritic cell function in-
volves two components thatdevelop in sequence: a presentation step in which anti-
gens are picked up in tissues like skin, and a sensitization activity in whichdendritic
cells acquire the capacity to induce a response in resting T lymphocytes, presum-
ably as the dendritic cells migrate to the draining lymphoid tissues like spleen and
lymph node.
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Materials and Methods
Mice.
￿
6-10-wk-old C57BL/6, BALB/c x DBA/2 [CxD2]F,, A, and B6.H-2k mice were
purchasedfrom TheTrudeauInstitute, (Saranac Lake, NY)and CBA/J mice were from The
Jackson Laboratories, (Bar Harbor, ME). Mice of both sexes 6-10 wk old, were used with
similar results.
Culture Medium.
￿
This was RPMI 1640 (Gibco Laboratories, Grand Island, NY) sup-
plementedwith 10% FCS (Hazelton Systems, Inc., Aberdeen, MD), 50 /AM 2-ME and 20 pg/
ml gentamicin.
This work was supported by grants AI-13013 and AI-19512 from the National Institutes of Health, by
a Max Kade Foundation Fellowship to N. Romani, and by a Medical Science Training Program
GM-07739 for S. Koide.
' Abbreviations used in this paper: GM, granulocyte/macrophage ; LC, Langerhans cell.
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Reagents.
￿
Sperm whale myoglobin was used directly from the manufacturer (Sigma Chem-
ical Co., St. Louis, MO; Fluka, Ronkonkoma, NY). Synthetic peptides, representing amino
acids 110-124, 110-121, 102-118, 69-84 were provided by Drs. J. Berzofsky (National Insti-
tutes of Health, Bethesda, MD) and J. Rothbard (Imperial Cancer Research Fund, London,
UK).
Antigen Presenting Cells.
￿
Spleen cells were depleted of erythrocytes by lysis with 0.83% am-
monium chloride in most experiments, and irradiated with 3,000 rad'3'Cs before use. Den-
dritic cells were low density spleen adherent cells that were depleted of B cells and macro-
phages by rosetting with antibody-coated RBC (12) and irradiated with 900 rad. LC were
isolated from mouse ear skin and enriched by a panning method as described (9). They were
irradiated with 900, 1,500, or 3,000 rad as indicated in the Results, but the dose of irradiation
did not influence accessory function. In some experiments, we used heterogeneous epidermal
suspensions, i.e., LC contaminated with keratinocytes, to verify that the panning procedure
did not alter the results observed with enriched LC . The A20 BALB/c H-2d B cell lymphoma
line was provided by Dr. Jay Berzofsky, NIH. These cells were treated with 50 p,g/ml mitomycin
c (Sigma Chemical Co.) for 75-85 min and washed three times before use.
T Cell Clones.
￿
These were described elsewhere (11), and included one that was restricted
to I-Ed (clone 11 .3 .7) and one restricted to I-Ad (clone 11.12 .8). To maintain the clones, the
cells were restimulated every 11-18 d with irradiated H-2d spleen cells plus 5-10 AM myo-
globin, generally one spleen equivalent and 106 cloned cells in a 25-cm2 flask (No. 25100;
Corning Glass Works, Corning, NY). For APC assays, the cloned T cells were taken 11-18 d
after boosting, isolated on Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ), and
2 x 104 T cells were stimulated with graded doses of APC in a final volume of0.2 ml medium
in flat-bottomed 96-well plates (No. 3596; Costar, Cambridge, MA). At 44-48 h, the cultures
were pulsed with 4 p,Ci/ml [3H]TdR for 16 h (6 Ci/mmol; ICN Radiochemicals, Irvine, CA).
All data are means of triplicates in which the standard deviations were <l0olo of the mean.
Primary MLR.
￿
T cells were nylon wool-nonadherent spleen and lymph nodes that were
generally depleted of Ia` cells with mAb and complement. 3 x 105 T cells were added per
well, and the MLRs were pulsed at 56-72 h as above.
Results
Spleen and A20 Lymphoma Cells, but not Mature Dendritic Cells, Present Myoglobin to a
Class II-restricted T Cell Clone. The two standard APC populations that are used
to study presentation of native proteins to mouse T cell clones and hybrids are bulk
spleen cells and the A20 lymphoma cell line. These were used to present myoglobin
to an MHC class II (I-Ed)-restricted clone 11.3.7 (11) and compared with two sources
of dendritic cells: spleen and cultured epidermal LC.
Both spleen and A20 presented myoglobin, but strikingly, the dendritic cells were
weak and sometimes inactive (Table I). Even a dose of 6 x 104 dendritic cells did
not elicit a significant response, whereas 103 cells elicit a strong allogeneic MLR
(see below). All of the populations could present a peptide fragment of myogloblin,
corresponding to amino acids 110-124 (Table I), although in many subsequent ex-
periments, presentation of peptide by dendritic cells was not as strong as spleen.
Previously it had been shown that the 110-124 peptide is 1-3 times more effective
on a molar basis than myoglobin for stimulating the clone (11), and we confirmed
this (data not shown). Presentation of peptide by dendritic cells required that they
be obtained from mice of the I-Ed MHC haplotype, i.e, H-2d, but not H-2b or H-2a
(Table I). In all cases, the proliferative response decreased threefold or more ifeither
the dose of APC or antigen was reduced threefold (not shown). We conclude that
spleen dendritic cells and cultured LC are quantitatively very weak at presenting
myoglobin to this T cell clone, in spite of their potent accessory function in primary
immune responses (7).ROMANI ET AL.
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TABLE I
A Comparison of Different Cell Types as APCfor a Myoglobin-speck T Cell Clone
Different populations ofAPC were tested for presentation of myoglobin (10 AM) or the indi-
cated peptides (3 pM) to the I-Ed-restricted clone 11 .3.7. Significant antigen-dependent
proliferative responses are underlined. Cultured LC were 3-d epidermal cell suspensions that
were enriched to >70% purity by floating the nonadherent epidermal cells on albumin columns.
Freshly Isolated Epidermal LCActively Present Myoglobin.
￿
Given the above findings,
wereasoned that there might bea stage in thelife history ofthedendritic cell where
it could pick up proteinantigens andthencarrytheseantigens toTcells, as indraining
lymphoid organs. There is evidence that dendritic cells can migrate to lymphoid
organs from tissues like skin and gut via the afferent lymph (6, 13). We therefore
compared freshly isolated epidermal LC with cultured LC fortheir capacitytopresent
myoglobin to T clones. It is known that fresh LC are relatively weak accessory cells
for primary T cell responses but do present antigens to sensitized T lymphoblasts
(8), which may be comparable to chronically stimulated T cell clones like 11.3.7.
In fact, freshly isolated LC were extremely active at presenting myoglobin (Table
II). 2 x 104 LC were more active than 1.5 x 105 spleen cells. Similar results were
obtained ifthe LC were partially enriched, using antiThy-1 mAb and complement
to deplete most keratinocytes, or were highly enriched by panning(Table II, Exps.
A and B). H-2d LC but not H-2k LC presented myoglobin. LC that were cultured
for 1 d could still present myoglobin, but LC that were cultured for 2-3 d were weak
or inactive (Table II). However, the cultured LC were active in presenting peptide
fragments (Table II).
Contrasting findings were made when these same APC populations were evalu-
ated as stimulators of the primary MLR. The day 3 cultured LC and splenic den-
dritic cells were the most active stimulators, while the fresh LC were weak (Fig. 1).
Fresh LCPresentMyoglobin to an I-A-restricted Clone.
￿
To extend the findings to a T
cell clone that is restricted to I-A, the other major class II locus ofthe mouse, we
studied clone 11.12.8 (11), which recognizes an epitope that includes glu 109, an im-
munodominant moiety for presentation of myoglobin on I-Ad molecules. Freshly
Exp. APC
Number
of APC
Proliferation of clone 11 .3 .7
No antigen Myoglobin 110-124 69-84
cpm x 10-3
1 None - 0.4 0.8 0 .6 0.5
Spleen cells 4 x 105 4.3 12.6 31 .7 7.4
A20 B cell lymphoma 5 x 104 5 .2 51 .9 73.4 5.5
Spleen dendritic cells 2 x 104 0.4 0.5 _7.6 0.8
Cultured H-2d LC 1 .5 x 104 8 .9 8.9 43.9 10.3
Cultured H-2a LC 1 .5 x 104 9.1 9.8 9.0 9.8
2 None - 0.3 0.4 0.4 0.4
Spleen cells 5 x 105 11 .5 64.8 133 .9 5.4
A20 B cell lymphoma 3 x 104 3 .1 40.1 68.7 5.1
Spleen dendritic cells 2 x 104 0.9 2.9 78 .8 1.7
3 Spleen cells 3 x 105 3.4 19.6 19.8
H-2d dendritic cells 3 x 104 0.5 2.6 43 .3
H-26 dendritic cells 7 x 104 3 .4 5.6 4.61172
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TABLE II
Freshly Isolated Epidermal LC Are Strong APC
Two experiments in which H-2d LC were isolated after different times in culture and used
as APC to present myoglobin protein (10 AM) and peptide (3 AM 110-124 in A; 20 AM 102-118
in B) to clone 11 .3.7. In Exp. A, the day 0 LC were enriched by panning; the day 1 LC were
enriched by culturing epidermal cells and depleting the nonadherent cells of residual Thy-1'
keratinocytes; and the day 3 LC were enriched by floating on dense albumin columns. In Exp.
B, all of the APC were treated with anti-Thy-1 and complement and the LC were panned with
antileukocyte mAb. Not shown are data where day 0 LC from an MHC-inappropriate strain
(CBA, H-2k) were found to be inactive (0 .5 x 10-3 cpm), which was the same result obtained
with no added APC.
isolated LC were again very active APC, while cultured LC were inactive (Table
III). Both types ofLC could present the 102-118 peptidebut not 110-121 (Table III).
To verify the specificity of peptide presentation, we tested the same peptides and
APC usingclone 11.3.7, which responds to 110-121 but only weakly to 102-118. Both
.A
0.0 0.01 0.1 1.0 10 100 1000
Cell Dose ( x 10-3)
FIGURE 1.
￿
The MLR stimulat-
ing activity of freshand cultured
LC, spleen dendritic cells (DC),
and unfractionated spleen.
Graded doses of the indicated
H-2d stimulator populations
were added to 3 x 10 la- , ny-
lon wool-nonadherent CD4' T
cells from allogeneic H-2k mice.
DNA synthesis was measured at
78-90 h. These same prepara-
tions were used to present myo-
globin in Table II, Exp. B.
Exp. APC
Dose
of APC
No
antigen
Proliferation of clone
Myoglobin
protein
Myoglobin
peptide
cmp x 10-3
A LC, day 0 2 x 104 0 .5 72.2 79 .1
5 x 103 0 .4 12.0 14.3
LC, day 1 2 x 104 1 .4 19.1 50.4
LC, day 3 2 x 104 1 .0 1 .0 80 .3
5 x 103 0.5 0.4 12 .1
Spleen 5 x 105 11 .7 118.8 118 .4
B LC, day 0 2 x 104 0.7 63.2 51 .6
6 x 103 0 .6 38.6 18 .0
LC, day 1 2 x 104 0.4 56.0 92 .0
6 x 103 0.4 25.3 26.1
LC, day 3 2 x 104 1 .0 6.2 91 .5
6 x 103 1 .3 2.1 34 .7
Spleen 5 x 105 3 .0 108.7 161 .7
1 .5 x 105 0.9 24.5 47 .0
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fresh and cultured LC presented peptide fragments to clones in an appropriately
specific manner (Table III).
MLR stimulation was evaluated with these same populations ofAPC. Again cul-
tured LC were more than 30 times as active as MLR stimulators than freshly iso-
lated LC, and more than 300 times more active than spleen (Table III). Therefore
the capacity of an APC to present a protein antigen to a sensitized T cell, and the
capacity to stimulate a primary immune response, represent distinct physiological
entities that develop in sequence when epidermal LC are cultured.
Discussion
Presentation and Sensitization Steps in TCell Stimulation.
￿
It is known that lymphoid
dendritic cells and cultured epidermal LC are powerful accessory cells for the trig-
gering ofTlymphocytes, andare 10-30 times moreactive thanpopulations offreshly
isolated LC (7-10, 14). We now find that the opposite holds true for the presentation
ofprotein antigens to T cell clones. Fresh LC are far more active than cultured LC
(Tables I-III).
These sets of findings at first seem inconsistent, but they can be interpreted if
one considers that APC can serve two broad functions, antigen presentation and
Tcell sensitization, andthat thesemay beindependently regulated in dendriticcells
and possibly other types of APC.
"Antigen presentation" generates the ligand that is recognized by thea/a hetero-
dimer ofthe clonally specific portion ofthe TCR for antigen-MHC. Presentation
typically requires thatthe antigen be denatured or processed in some way such that
the antigen or antigen fragment (15-19) can associatewith a peptide binding groove
on the external aspect of the MHC product (20). It is not possible to quantitate
the amount ofpresented antigen directly. Instead, one measures the capacity of an
APC to stimulate a T cell ("accessory function"). However, it is likely that the rela-
tive deficiency of cultured LC and spleen dendritic cells to stimulate myoglobin-
specific clones involves a lesion in myoglobin processing and presentation sincethese
same cultured LC do present peptide fragments and actively stimulate T cells in
the MLR (Fig. 1, Table III).
"Sensitization" refers to the events that arerequired in addition to antigen presen-
tation to make T cells begin to produce their differentiated products, lymphokines
and cytolysins, and to become more responsive to growth factors. The distinction
betweenantigen presentation and sensitization became evident instudies ofthe MLR.
It was found that dendritic cells were active MLR stimulators. Other cellslike mac-
rophages and B lymphocytes were less active but did not lack antigen, since they
could present transplantation antigens in an MHC-restricted way toTlymphoblasts
that had first been sensitized by dendritic cells (21, 22). Likewise, freshly isolated
LC could stimulate T blasts but not resting T cells (8).
Once a T cell becomes an IL-2-responsive lymphoblast, it effectively binds and
responds to many types ofAPC, even those fixed with aldehydes (21). Chronically
stimulated T cell clones correspond in functional respects to lymphoblasts, since
both are recently stimulated with antigen and areIL-2 responsive. Therefore, long-
term clonal populations ofT cells are valuable models for monitoring presentation
or "antigenicity" but they do not necessarily provide information on "immunoge-
nicity," that is, the sensitization requirements for resting T cells.ROMANI ET AL.
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In the accompanying paper (14) evidence also was presented for a dissociation
ofpresentation and sensitization functions in the response to the mitogenanti-CD3.
In the anti-CD3 model, Fc receptors on the LC presentanti-CD3 mAb as theligand
for the TCR. Freshly isolated LC likely have much more ligand (10 times more Fc
receptors) but are much less active than cultured LC as sensitizing cells for the T
cell proliferative response.
Mechanisms for Presentation of Proteins by Dendritic Cells.
￿
For antigen presentation
by MHC class II molecules, peptide fragments ofthe original antigen might be gener-
ated either by extracellular (19) or by intracellular (15) proteolysis. Lymphoid den-
dritic cells and cultured epidermal LC show little endocytic activity (7, 23), at least
as judged by the accumulation of tracer proteins and particulates. This minimal
endocytic activity might account for the observed deficit in the ability to present
myoglobin.
Freshly isolated LC, which do present myoglobin, may be capable of some endo-
cytic activity. Wolff and Schreiner (24) documented uptake of horseradish peroxi-
dase in situ after administration of protein subcutaneously. With freshly isolated
LC, Schuleret al. (25) noted uptake of staphylococci (25), Takigawa et al. (26) noted
uptake of lectins, and Hanau et al. (27) noted internalization of the mAb anti-CD1
and anti-HLA-DR. Since we study spleen dendritic cells after a day in culture, it
is also possible that these cells in situ or freshly upon isolation, can exhibit enough
endocytic function to present myoglobin.
An additional possibility would be that LC acquire antigens from extracellular
proteolysis, as from proteases released during an inflammatory response in skin or
from other cell types such as macrophages. Given the lack of presenting function
by cultured lymphoid dendritic cells and epidermal LC, it would be possible to test
this hypothesis by mixing macrophages of the inappropriate MHC and dendritic
cells of the appropriate H-2d MHC. We do know that keratinocytes, i.e., Ia- epi-
dermal suspensions, are unable to process myoglobin for the cultured LC. We also
need to test in detail the efficacy of mature dendritic cells to present peptide frag-
ments, i.e., to comparedendritic cells and other APC using a range ofpeptide doses
and sequences. Our current experiments indicate that lymphoid dendritic cells-are
less effective than epidermal LC and bulk spleen in presenting peptides.
Lymphoid dendritic cells and cultured epidermal LC stimulate helper T cell-de-
pendent antibody responses, while fresh LC are inactive (8, 28). There are several
possibilities to account for the presentation function of dendritic cells in this situa-
tion : (a) The preparation of antigen (red cells or hapten-carrier conjugates) may
have containedimmunogenic fragmentsor "preprocessed" antigen; (b) thedendritic
cells may have participated in a strong syngeneic MLR, which in turn may have
induced a processing capacity; (c) sufficient processing may have occurred intra- or
extracellularly to present to helper T cells; (d) The dendritic cell preparations may
have contained a small subset of actively processing cells some ofwhichhad the fea-
turesof fresh LC. A small subset might go unnoticed in ourcurrentstudies in which
relatively large doses of APC are needed to stimulate the T cell clones.
What Is a Transplantation Antigen?
￿
Major transplantation antigens are equated to
allogeneic MHC molecules, but the latter may have to become occupied with pep-
tides to be recognized by T lymphocytes (20). Since our data show that dendritic
cells in tissues effectively form MHC-myoglobin complexes, we would suggest that1176
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the strong MLR stimulatingactivity of cultured epidermal LC, andmost likely den-
dritic cells from lymph, blood, andlymphoid organs (29), reflects the fact that these
cells previously have processed antigens and acquired the capacities of this lineage to
initiate T cell responses like the MLR. This hypothesis can be tested by studying
dual-reactive T cell clones that respond either to self-MHC plus protein or to al-
logeneic MHC. Only in the latter situation should spleen dendritic cells and cul-
tured LC be active APC.
TheSpecialized Properties ofDendritic Cells as Presenting Cells.
￿
The specialized prop-
erties of dendritic cells for initiating the immune response have been reviewed else-
where(30, 31) and include: high levels of MHC products; ability to cluster antigen-
specific lymphocytes for days and to induce lymphokine production andfunctioning
IL-2 receptors; capacity to home to the T-dependent regions of lymphoid organs;
and mobilization from immature precursors in tissues in response to a specific cytokine,
GM-CSF, which might be released as an early event after deposition of antigen.
It now appears that the handling of antigens by dendritic cells is also distinctive
in that handling of intact proteins can be downregulated when the dendritic cells
mature and/or leave a tissue to migrate to a lymphoid organ. It is of interest that
LC also upregulate expression of MHC products some fivefold over the first 12-18
h of culture (32). This is the time that LC handle exogenousproteins, therebyproviding
an excellent means for charging the MHC products on tissue dendritic cells with
the specific antigen that is deposited in that site. The epidermal dendritic cell, and
possibly dendritic cells in other nonlymphoid organs, therefore are specialized to
act as "sentinels" for the deposition of antigens that are to stimulate T cells, as sug-
gested for contact allergens (33). As a result of the capacity to regulate the acquisi-
tion of antigen, the dendritic cells that emerge from nonlymphoid tissues (into the
blood or lymph) primarily present proteins acquired there. By decreasing further
processing, dendritic cells might not displace previously acquired peptides through
the handling of additional materials, especially self proteins. During transplanta-
tion, this would provide a powerful source of transplant-derived antigens. During
physiologic responses, the possibility of autoimmunity should also be reduced since
dendriticcells wouldnot be handling self proteins afterthey leave the site of antigen
deposition.
Summary
The capacity of dendritic cells to present protein antigens has been studied with
two MHC class II-restricted, myoglobin-specific, Tcell clones. Spleen dendritic cells
and cultured epidermal Langerhans cells (LC) presented native myoglobin weakly
andoftennot at all. These same populationswere powerful stimulators of allogeneic
T cells in the primary MLR. Freshly isolated LC were in contrast very active in
presenting proteins to T cell clones but were weak stimulators of the MLR. Both
fresh and cultured LC could present specific peptide fragments ofmyoglobin to the
clones. These results suggest that dendritic cells in nonlymphoid tissues like skin
can actas sentinels forpresenting antigens in situ, theiraccessoryfunction developing
in twophases. Firstantigens arecaptured andappropriately presented. Further han-
dling ofantigen then is downregulatedwhile the cells acquire strong sensitizing ac-
tivity for the growth and function of resting T lymphocytes. The potent MLR
stimulating activity of cultured epidermal LC and lymphoid dendritic cells prob-ably reflects priorhandling of antigens leading to the formation of allogeneic MHC-
peptide complexes.
The authors are grateful to Drs. J. Berzofsky andJ . Rothbard for providing valuable reagents
during our initial experiments.
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